TY - JOUR
T1 - Gender Differences in Takotsubo Syndrome
AU - Arcari, Luca
AU - Núñez Gil, Iván J.
AU - Stiermaier, Thomas
AU - El-Battrawy, Ibrahim
AU - Guerra, Federico
AU - Novo, Giuseppina
AU - Musumeci, Beatrice
AU - Cacciotti, Luca
AU - Mariano, Enrica
AU - Caldarola, Pasquale
AU - Parisi, Giuseppe
AU - Montisci, Roberta
AU - Vitale, Enrica
AU - Sclafani, Matteo
AU - Volpe, Massimo
AU - Corbì-Pasqual, Miguel
AU - Martinez-Selles, Manuel
AU - Almendro-Delia, Manuel
AU - Sionis, Alessandro
AU - Uribarri, Aitor
AU - Akin, Ibrahim
AU - Thiele, Holger
AU - Brunetti, Natale Daniele
AU - Eitel, Ingo
AU - Santoro, Francesco
N1 - Publisher Copyright:
© 2022 American College of Cardiology Foundation
PY - 2022/5/31
Y1 - 2022/5/31
N2 - Background: Male sex in takotsubo syndrome (TTS) has a low incidence and it is still not well characterized. Objectives: The aim of the present study is to describe TTS sex differences. Methods: TTS patients enrolled in the international multicenter GEIST (GErman Italian Spanish Takotsubo) registry were analyzed. Comparisons between sexes were performed within the overall cohort and using an adjusted analysis with 1:1 propensity score matching for age, comorbidities, and kind of trigger. Results: In total, 286 (11%) of 2,492 TTS patients were men. Male patients were younger (age 69 ± 13 years vs 71 ± 11 years; P = 0.005), with higher prevalence of comorbid conditions (diabetes mellitus 25% vs 19%; P = 0.01; pulmonary diseases 21% vs 15%; P = 0.006; malignancies 25% vs 13%; P < 0.001) and physical trigger (55 vs 32% P < 0.01). Propensity-score matching yielded 207 patients from each group. After 1:1 propensity matching, male patients had higher rates of cardiogenic shock and in-hospital mortality (16% vs 6% and 8% vs 3%, respectively; both P < 0.05). Long-term mortality rate was 4.3% per patient-year (men 10%, women 3.8%). Survival analysis showed higher mortality rate in men during the acute phase in both cohorts (overall: P < 0.001; matched: P = 0.001); mortality rate after 60 days was higher in men in the overall (P = 0.002) but not in the matched cohort (P = 0.541). Within the overall population, male sex remained independently associated with both in-hospital (OR: 2.26; 95% CI: 1.16-4.40) and long-term mortality (HR: 1.83; 95% CI: 1.32-2.52). Conclusions: Male TTS is featured by a distinct high-risk phenotype requiring close in-hospital monitoring and long-term follow-up.
AB - Background: Male sex in takotsubo syndrome (TTS) has a low incidence and it is still not well characterized. Objectives: The aim of the present study is to describe TTS sex differences. Methods: TTS patients enrolled in the international multicenter GEIST (GErman Italian Spanish Takotsubo) registry were analyzed. Comparisons between sexes were performed within the overall cohort and using an adjusted analysis with 1:1 propensity score matching for age, comorbidities, and kind of trigger. Results: In total, 286 (11%) of 2,492 TTS patients were men. Male patients were younger (age 69 ± 13 years vs 71 ± 11 years; P = 0.005), with higher prevalence of comorbid conditions (diabetes mellitus 25% vs 19%; P = 0.01; pulmonary diseases 21% vs 15%; P = 0.006; malignancies 25% vs 13%; P < 0.001) and physical trigger (55 vs 32% P < 0.01). Propensity-score matching yielded 207 patients from each group. After 1:1 propensity matching, male patients had higher rates of cardiogenic shock and in-hospital mortality (16% vs 6% and 8% vs 3%, respectively; both P < 0.05). Long-term mortality rate was 4.3% per patient-year (men 10%, women 3.8%). Survival analysis showed higher mortality rate in men during the acute phase in both cohorts (overall: P < 0.001; matched: P = 0.001); mortality rate after 60 days was higher in men in the overall (P = 0.002) but not in the matched cohort (P = 0.541). Within the overall population, male sex remained independently associated with both in-hospital (OR: 2.26; 95% CI: 1.16-4.40) and long-term mortality (HR: 1.83; 95% CI: 1.32-2.52). Conclusions: Male TTS is featured by a distinct high-risk phenotype requiring close in-hospital monitoring and long-term follow-up.
UR - http://www.scopus.com/inward/record.url?scp=85130352337&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2022.03.366
DO - 10.1016/j.jacc.2022.03.366
M3 - Journal articles
C2 - 35618345
AN - SCOPUS:85130352337
SN - 0735-1097
VL - 79
SP - 2085
EP - 2093
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 21
ER -